[1]Isla D, Majem M, Violas N, et al. A consensus statement on the gender perspective in lung cancer[J]. Clin Transl Oncol, 2016, 19(5): 1-9.
[2]陈万青, 孙可欣, 郑荣寿, 等. 2014年中国分地区恶性肿瘤发病和死亡分析[J]. 中国肿瘤, 2018, 23(1): 1-14.
[3]杨付红, 张春娣. 肺癌的研究现状[J]. 中国继续医学教育, 2015, 20(2): 30-31.
[4]Cotter TG. Apoptosis and cancer: the genesis of a research field[J]. Nat Rev Cancer, 2009, 9(7): 501-507.
[5]Hanahan D, Weinberg R. Hallmarks of cancer: the next generation [J]. Cell, 2011, 144(5): 646-674.
[6]Wood HB. TMEM106B is a susceptibility locus for Ftld [J]. Nat Rev Neurol, 2010, 6(4): 184.
[7]Finch N,Carrasquillo MM,Baker M,et al.TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers[J].Neurology,2011,76(5):467-474.
[8]Van dZJ, Van LT, Kleinberger G, et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort [J]. Brain, 2011, 134(2): 808-815.
[9]Xu D, Qu L, Hu J, et al. Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis [J]. J Cel Mol Med, 2014, 18(8): 1655-1666.
[10]Wu CL, Xu J, Wang H, et al. TMEM106a is a novel tumor suppressor in human renal cancer [J]. Kid Blood Press Res, 2017, 42(5): 853.
[11]许冬, 姜静远, 许晨彤, 等. 跨膜蛋白TMEM106A诱导肝癌细胞HepG2巨泡样死亡[J]. 中国生物化学与分子生物学报, 2017, 30(1): 44-50.
[12]钟良瑞, 陈华, 景晶, 等. 三叶青黄酮抑制肺癌A549细胞生长与蛋白酶体活性的关系研究[J]. 中国临床药理学与治疗学, 2017, 22(10): 1123-1126.
[13]Elmore S. Apoptosis: a review of programmed cell death [J]. Toxicol Pathol, 2013, 35: 495-516.
[14]Horvitz HR. Genetic control of programmed cell death in the nematode Caenorhabditis elegans [J]. Cell, 1986, 44(6): 817-829.
[15]Sager R. Tumor suppressor genes in the cell cycle [J]. Curr Opin Cell Biol, 1992, 4(2): 155.
[16]Das PM, Singal R. DNA methylation and cancer [J]. J Clin Oncol, 2004, 22(22): 4632-4642.
[17]Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions [J]. Exp Biol Med, 2004, 229(10): 988.
[18]Brown R, Strathdee G. Epigenomics and epigenetic therapy of cancer [J]. Trend Mol Med, 2002, 8(4): S43-S48. |